Evidence map›Paper›PMID 38934168›Full record

Observational studyPathobiology : journal of immunopathology, molecular and cellular biology2024

Multiplex Intraoperative Rapid Immunohistochemistry with Noncontact Antibody Mixing for Distinguishing the Histologic Phenotype of Lung Cancer.

Shoji Kuriyama, Kazuhiro Imai, Hiroshi Nanjo, Yuki Wakamatsu, Shinogu Takashima, Tsubasa Matsuo, Hidenobu Iwai, Ryo Demura, Haruka Suzuki, Yuzu Harata and 5 more

Abstract readObservational Study
In one paragraph

Observational study in Pathobiology : journal of immunopathology, molecular and cellular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Shoji KuriyamaDepartment of Thoracic Surgery, Akita University Graduate School of Medicine, Akita, Japan, syommf1u@gipc.akita-u.ac.jp.
Kazuhiro ImaiDepartment of Thoracic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
Hiroshi NanjoDepartment of Pathology, Akita University Graduate School of Medicine, Akita, Japan.
Yuki WakamatsuDepartment of Thoracic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
Shinogu TakashimaDepartment of Thoracic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
Tsubasa MatsuoDepartment of Thoracic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
Hidenobu IwaiDepartment of Thoracic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
Ryo DemuraDepartment of Thoracic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
Haruka SuzukiDepartment of Thoracic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
Yuzu HarataDepartment of Thoracic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
Sumire ShibanoDepartment of Thoracic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
Akiyuki WakitaDepartment of Thoracic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
Yusuke SatoDepartment of Thoracic Surgery, Akita University Graduate School of Medicine, Akita, Japan.
Kyoko NomuraDepartment of Health Environmental Science and Public Health, Akita University, Akita, Japan.
Yoshihiro MinamiyaDepartment of Thoracic Surgery, Akita University Graduate School of Medicine, Akita, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDetermining a surgical strategy for early-stage lung cancer requires an accurate histologic diagnosis. Immunohistochemistry (IHC) enables reliable diagnosis of histological types but requires more time and more tumor tissue slides than hematoxylin and eosin staining. We aimed to assess the clinical validity of a new rapid multiplex IHC technique utilizing alternating current (AC) mixing for intraoperative lung cancer diagnosis.

methodsForty-three patients who underwent radical resection of lung cancers were enrolled in a retrospective observational study. Frozen sections were prepared from lung tumor samples, and rapid IHC employing AC mixing was implemented alongside a multiplex IHC protocol targeting thyroid transcription factor-1 + cytokeratin 5, desmoglein 3 + Napsin A, and p63 + tripartite motif containing 29. We then evaluated the concordance between intraoperative diagnoses derived from rapid multiplex IHC and final pathology.

resultsThe concordance rate between the pathological diagnosis made with added rapid multiplex IHC and the final pathology was 93.0% (Cohen's 𝜅 coefficient = 0.860 and 95% CI: 0.727-0.993). When considering only adenocarcinoma and squamous cell carcinoma, the diagnoses were in agreement for all cases.

conclusionsWe suggest rapid multiplex IHC as a promising tool for determining surgical strategies for lung tumors.

Indexed as

ImmunohistochemistryLung NeoplasmsAdenocarcinomaAdultAgedAged, 80 and overBiomarkers, TumorCarcinoma, Squamous CellDesmoglein 3FemaleHumansKeratin-5MaleMiddle AgedPhenotypeRetrospective StudiesBiomarkers, TumorDesmoglein 3Keratin-5Thyroid Nuclear Factor 1Alternating current field mixingFrozen sectionImmunohistochemistryLung cancerSurgery

Identifiers

PMID38934168
PMCPMC11614303

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.